Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1993-5-13
pubmed:abstractText
1. The regional binding of [3H]-(+)-5-methyl-10,11-dihydro-5H-dibenzo (a,d)cyclohepten-5,10-imine maleate ([3H]-(+)-MK 801) to sections of rat brain was measured by an in vitro quantitative autoradiographic technique. A heterogeneous distribution of binding sites was observed. 2. High values of binding were detected in the hippocampal formation and cerebral cortex, while very low binding was found in cerebellum. [3H]-(+)-MK 801 binding was not detectable in white matter tracts or in the brain stem. 3. [3H]-(+)-MK 801 binding was inhibited by increasing concentrations of both 7-chlorokynurenate (1-1000 microM) and ((+)-2-carboxypiperazine-4-yl)propyl-1-phosphonic acid (CPP) (0.1-100 microM). High concentrations of both drugs were able to inhibit completely specific [3H]-(+)-MK 801 binding. 4. IC50 values calculated for both 7-chlorokynurenate and CPP-induced [3H]-(+)-MK 801 binding inhibition were similar in all brain regions analyzed. 5. The inhibitory action of 7-chlorokynurenate and that of CPP on [3H]-(+)-MK 801 binding were reversed by addition of glycine and glutamate respectively. 6. It is concluded that activation of glycine and N-methyl-D-aspartate (NMDA) receptors is obligatory for the binding of [3H]-(+)-MK 801 to occur in all of the brain regions examined in the present study. Furthermore, on the basis of the similar regional sensitivities of [3H]-(+)-MK 801 binding to the inhibitory action of 7-chlorokynurenate and CPP, a single pharmacological classification of the NMDA receptor complex in brain is suggested. The cerebellum was not included in the study due to the very low level of [3H]-(+)-MK 801 binding detected under the experimental conditions used.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-1676144, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-1682157, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-1694710, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-1968086, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2169959, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2188577, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2433595, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2448800, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2536176, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2543272, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2557130, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2566140, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2823273, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2841759, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2842779, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2873045, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-2876750, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-3022881, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-3031504, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-3031525, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-3291999, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-6093256, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-6112965, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-6138738, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-6142499, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-6151863, http://linkedlifedata.com/resource/pubmed/commentcorrection/8096780-686171
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0007-1188
pubmed:author
pubmed:issnType
Print
pubmed:volume
108
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
577-82
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Inhibition of [3H]-(+)-MK 801 binding to rat brain sections by CPP and 7-chlorokynurenic acid: an autoradiographic analysis.
pubmed:affiliation
Glaxo Research Laboratories, Verona, Italy.
pubmed:publicationType
Journal Article, In Vitro